Dimitri P. Mikhailidis
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 85
-
- Cardiovascular Health and Disease Prevention 24
- Surgery top 0.2%
- Lipoproteins and Cardiovascular Health 186
- Peripheral Artery Disease Management 27
- Nephrology top 0.5%
- Internal Medicine top 1%
-
- Cancer, Lipids, and Metabolism 55
-
- Health Systems, Economic Evaluations, Quality of Life 31
- Pharmaceutical Economics and Policy 22
-
- Cerebrovascular and Carotid Artery Diseases 30
Dimitri P. Mikhailidis
419 papers receiving 14.4k citations
Hit Papers
Peers
Comparison fields: 5 of 164
- Endocrinology, Diabetes and Metabolism 3.4k
- Cardiology and Cardiovascular Medicine 3.4k
- Surgery 6.2k
- Nephrology 937
- Internal Medicine 449
Countries citing papers authored by Dimitri P. Mikhailidis
This map shows the geographic impact of Dimitri P. Mikhailidis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dimitri P. Mikhailidis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dimitri P. Mikhailidis more than expected).
Fields of papers citing papers by Dimitri P. Mikhailidis
This network shows the impact of papers produced by Dimitri P. Mikhailidis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dimitri P. Mikhailidis. The network helps show where Dimitri P. Mikhailidis may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dimitri P. Mikhailidis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 7 | |
| 4 | 2022 | 2 | |
| 5 | 2022 | 11 | |
| 6 | Low serum albumin: A neglected predictor in patients with cardiovascular diseasebreakdown → | 2022 | 151 |
| 7 | 2021 | 20 | |
| 8 | 2021 | 12 | |
| 9 | 2021 | 12 | |
| 10 | 2019 | 20 | |
| 11 | 2019 | 10 | |
| 12 | 2011 | 11 | |
| 13 | 2010 | 1 | |
| 14 | 2010 | 194 | |
| 15 | Clinical research Decreased kidney function as a risk factor for cardiovascular events in subjects with metabolic syndrome – a pilot study | 2009 | 3 |
| 16 | 2008 | 10 | |
| 17 | 2007 | 2 | |
| 18 | Early statin therapy in patients with acute coronary syndrome. | 2005 | 10 |
| 19 | The effect of superoxide dismutase on nitric oxide-mediated and electrical field stimulated diabetic rabbit cavernosal smooth muscle relaxation | 2000 | 1 |
| 20 | 1990 | 3 |
About Dimitri P. Mikhailidis
Dimitri P. Mikhailidis is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine, having authored 421 papers that have together received 14.8k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (186 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (85 papers), Cancer, Lipids, and Metabolism (55 papers), Health Systems, Economic Evaluations, Quality of Life (31 papers), Cerebrovascular and Carotid Artery Diseases (30 papers), Peripheral Artery Disease Management (27 papers), Cardiovascular Health and Disease Prevention (24 papers) and Pharmaceutical Economics and Policy (22 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.4k citations), Cardiology and Cardiovascular Medicine (3.4k citations) and Surgery (6.2k citations). Dimitri P. Mikhailidis has collaborated with scholars based in United Kingdom, Greece and Poland. Frequent co-authors include Maciej Banach, Jacek Rysz, Moses Elisaf, Vasilios G. Athyros, Armen Yuri Gasparyan, George D. Kitas, Amirhossein Sahebkar, Lilit Ayvazyan, Asterios Karagiannis and Kosmas I. Paraskevas. Their work appears in journals such as The Lancet, Journal of the American College of Cardiology and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.